Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?

被引：0
|
作者：
Kadri Altundag
机构：
[1] MKA Breast Cancer Clinic,
来源：
Breast Cancer Research and Treatment | 2018年 / 167卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 815
相关论文
共 50 条
  • [1] Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?
    Altundag, Kadri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 815 - 815
  • [2] Duration of trastuzumab in patients with HER2-positive metastatic breast cancer in prolonged remission
    Haq, R.
    Gulasingam, P.
    CURRENT ONCOLOGY, 2016, 23 (02) : 91 - 95
  • [3] Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
    T. G. Steenbruggen
    N. I. Bouwer
    C. H. Smorenburg
    H. N. Rier
    A. Jager
    K. Beelen
    A. J. ten Tije
    P. C. de Jong
    J. C. Drooger
    C. Holterhues
    J. J. E. M. Kitzen
    M. -D. Levin
    G. S. Sonke
    Breast Cancer Research and Treatment, 2019, 178 : 597 - 605
  • [4] Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
    Steenbruggen, T. G.
    Bouwer, N. I.
    Smorenburg, C. H.
    Rier, H. N.
    Jager, A.
    Beelen, K.
    ten Tije, A. J.
    de Jong, P. C.
    Drooger, J. C.
    Holterhues, C.
    Kitzen, J. J. E. M.
    Levin, M-D.
    Sonke, G. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 597 - 605
  • [5] Duration of trastuzumab for HER2-positive breast cancer
    Montemurro, Filippo
    Aglietta, Massimo
    LANCET ONCOLOGY, 2013, 14 (08): : 678 - 679
  • [6] Duration of trastuzumab maintenance in HER2-positive metastatic breast cancer patients with radiological complete remission: Robust predictive markers are needed!
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (02): : 1269 - 1269
  • [7] Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature
    Isabel Ihnenfeld Arciénega
    Patrick Imesch
    Daniel Fink
    Konstantin J. Dedes
    Targeted Oncology, 2015, 10 : 297 - 301
  • [8] Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature
    Arcienega, Isabel Ihnenfeld
    Imesch, Patrick
    Fink, Daniel
    Dedes, Konstantin J.
    TARGETED ONCOLOGY, 2015, 10 (02) : 297 - 301
  • [9] DISEASE CHARACTERISTICS IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS ACHIEVING COMPLETE REMISSION DURING TRASTUZUMAB THERAPY
    Susnjar, Snezana
    Jankovic, Radmila
    Jovanic, Irena
    BREAST, 2013, 22 : S46 - S46
  • [10] Trastuzumab emtansine in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
12345